Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-1426

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy ; volume:5 ; number:1 ; day:16 ; month:5 ; year:2017 ; pages:1-18 ; date:12.2017
Journal for ImmunoTherapy of Cancer ; 5, Heft 1 (16.5.2017), 1-18, 12.2017

Keyword: Krebs
Onkologie

Creator: Gnjatic, Sacha

Contributor: Bronte, Vincenzo
Brunet, Laura Rosa
Butler, Marcus O.
Disis, Mary L.
Galon, Jerome
Hakansson, Leif G.
Hanks, Brent A.
Karanikas, Vaios
Khleif, Samir N.
Kirkwood, John M.
Miller, Lance D.
Schendel, Dolores J.
Tanneau, Isabelle
Wigginton, Jon M.
Butterfield, Lisa H.
SpringerLink (Online service)

DOI: 10.1186/s40425-017-0243-4

URN: urn:nbn:de:1111-201705225895

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Gnjatic, Sacha
Bronte, Vincenzo
Brunet, Laura Rosa
Butler, Marcus O.
Disis, Mary L.
Galon, Jerome
Hakansson, Leif G.
Hanks, Brent A.
Karanikas, Vaios
Khleif, Samir N.
Kirkwood, John M.
Miller, Lance D.
Schendel, Dolores J.
Tanneau, Isabelle
Wigginton, Jon M.
Butterfield, Lisa H.
SpringerLink (Online service)

Other Objects (12)

Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy

Establishing a model composed of immune-related gene-modules to predict tumor immunotherapy response

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy

Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma

Identifying neoantigens for use in immunotherapy

Fullerene‐Based Immunoregulatory Nanomaterials for Immunotherapy of Tumor and Immune‐Related Inflammatory Diseases

An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer

Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy

Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis

Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility

Comparing methods to predict baseline mortality for excess mortality calculations

Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy

Establishing a model composed of immune-related gene-modules to predict tumor immunotherapy response

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy

Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma

Identifying neoantigens for use in immunotherapy

Fullerene‐Based Immunoregulatory Nanomaterials for Immunotherapy of Tumor and Immune‐Related Inflammatory Diseases

An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer

Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy

Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis

Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility

Comparing methods to predict baseline mortality for excess mortality calculations

Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy

Establishing a model composed of immune-related gene-modules to predict tumor immunotherapy response

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy

Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma

Identifying neoantigens for use in immunotherapy

Fullerene‐Based Immunoregulatory Nanomaterials for Immunotherapy of Tumor and Immune‐Related Inflammatory Diseases

An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer

Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy

Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis

Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility

Comparing methods to predict baseline mortality for excess mortality calculations

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy

Establishing a model composed of immune-related gene-modules to predict tumor immunotherapy response

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy

Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma

Identifying neoantigens for use in immunotherapy

Fullerene‐Based Immunoregulatory Nanomaterials for Immunotherapy of Tumor and Immune‐Related Inflammatory Diseases

An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer

Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy

Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis

Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility

Comparing methods to predict baseline mortality for excess mortality calculations

Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy

Establishing a model composed of immune-related gene-modules to predict tumor immunotherapy response

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy

Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma

Identifying neoantigens for use in immunotherapy

Fullerene‐Based Immunoregulatory Nanomaterials for Immunotherapy of Tumor and Immune‐Related Inflammatory Diseases

An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer

Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy

Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis

Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility

Comparing methods to predict baseline mortality for excess mortality calculations

Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy

Establishing a model composed of immune-related gene-modules to predict tumor immunotherapy response

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy

Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma

Identifying neoantigens for use in immunotherapy

Fullerene‐Based Immunoregulatory Nanomaterials for Immunotherapy of Tumor and Immune‐Related Inflammatory Diseases

An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer

Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy

Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis

Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility

Comparing methods to predict baseline mortality for excess mortality calculations

Related objects

Reset password